Primary Hyperparathyroidism: Clinical Trials

4 trials for Primary Hyperparathyroidism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 32Completed 2

Follow Primary Hyperparathyroidism: new trials by email Literature Review of Primary Hyperparathyroidism trials Research Report on Primary Hyperparathyroidism

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism
eplerenone, amiloride, Placebo - Primary Hyperparathyroidism
Phase 2 / Phase 3CompletedBrigham and Women's Hospital692016-01-012023-05-03
Effect of Vitamin D Treatment in Primary Hyperparathyroidism
Cholecalciferol - Vitamin D Deficiency, Primary Hyperparathyroidism
Phase 2 / Phase 3CompletedUniversity of Aarhus462008-05-012013-11-18
Safety, Tolerability, and Clinical Effects of Twice-daily Doses of Cinacalcet (AMG 073) in Adults With Primary Hyperparathyroidism (HPT)
Cinacalcet, Placebo - Primary Hyperparathyroidism
Phase 2CompletedAmgen102000-06-152018-12-14
Safety, Pharmacokinetics, and Clinical Effects of Cinacalcet (AMG 073) in Primary Hyperparathyroidism
Cinacalcet, Placebo - Primary Hyperparathyroidism
Phase 2CompletedAmgen481998-09-292018-12-13

Narrower conditions

Hyperparathyroidism, Primary (4)  ·  Hypercalcemia (1)  ·  Vitamin D Deficiency (1)

Broader conditions

Endocrine System Diseases (4)  ·  Hyperparathyroidism (4)  ·  Parathyroid Diseases (4)  ·  Avitaminosis (1)  ·  Calcium Metabolism Disorders (1)  ·  Deficiency Diseases (1)  ·  Malnutrition (1)  ·  Metabolic Diseases (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Water-Electrolyte Imbalance (1)

Interventions

Cinacalcet (3)  ·  Amiloride (1)  ·  Cholecalciferol (1)  ·  Eplerenone (1)  ·  Vitamin D (1)

Sponsors

Amgen (2)  ·  Brigham and Women's Hospital (1)  ·  University of Aarhus (1)

Countries

Denmark (1)  ·  United States (1)

Top investigators

Anand Vaidya, MD MMSc (1)  ·  Lars Rejnmark, MD,PhD,DrMed (1)  ·  Lars Rolighed, MD (1)

Results publications

PMID 35018442